The treatment of multiple sclerosis (MS) has changed over the last 20 years. All
immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a …

Neuropsychiatric abnormalities may be broadly divided in two categories: disorders of
mood, affect, and behavior and abnormalities affecting cognition. Among these conditions …

There is growing evidence of a relationship between inflammation and psychiatric illness. In
particular, the cytokine Interleukin-6 (IL-6) has been linked to stress-related disorders such …

Depressive disorders are common in patients with multiple sclerosis, influencing their quality
of life and adherence to treatments, as well as becoming more frequent with the progression …

To detect multiple sclerosis (MS) diseases early, we proposed a novel method on the
hardware of magnetic resonance imaging, and on the software of three successful methods …

Multiple sclerosis (MS) is the most famous autoimmune disease attacking the central
nervous system. It attacks people from age 20–50 years old and the females' attacks double …

Major depressive disorder (MDD) is a common condition that afflicts the general population
across a broad spectrum of ages and social backgrounds. MDD has been identified by the …

The current understanding of major depressive disorder (MDD) and bipolar disorder (BD) is
plagued by a cacophony of controversies as evidenced by competing schools to understand …

Oxidative stress has been suggested to play a key role in multiple sclerosis (MS), but clinical
data on oxidative stress markers in MS patients were inconsistent. This study sought to …

Depressive disorders appear relatively frequently in older patients, and therefore represent
an important disease burden worldwide. Given the high levels of inflammatory parameters …